文献速递颈动脉与弓上血管

初次颈动脉狭窄复发血运重建的结局:系统评价与荟萃分析

A Systematic Review and Meta-Analysis of Outcome After Repeat Revascularization for Primary Carotid Artery Restenosis.
PubMed 文献 · J Endovasc Ther · 2025-06-21

该系统评价与荟萃分析纳入19项研究、10,041例患者共10,171次手术,比较CAS与CEA治疗初次颈动脉复发狭窄的结局。总体主要终点无差异,但校正症状状态后CEA的TIA/任何卒中发生率更高(OR 2.05),CEA的心梗发生率也更高(OR 1.85),CEA组颅神经损伤发生率为7.56%。基于有限质量研究,CAS似乎更可取。

要点

  • 总体主要终点CAS与CEA无差异,校正症状状态后CEA的TIA/任何卒中风险更高
  • CEA心梗发生率显著高于CAS(OR 1.85)
  • 颅神经损伤仅见于CEA组(7.56%),多为一过性

核心结论

  • 基于有限质量、多为回顾性非随机设计的研究,CAS与CEA均为初次复发狭窄可行的治疗方式,主要结局相当,但CAS似乎更可取。

主要发现

  • 总体主要终点(TIA或任何卒中)无差异;校正症状状态后CEA的TIA/任何卒中发生率高于CAS(OR 2.05, 95%CI 1.29-3.27, p<0.01)。
  • CEA的心梗发生率显著高于CAS(OR 1.85, 95%CI 1.19-2.86, p<0.01)。
  • 颅神经损伤仅见于CEA组(7.56%, 95%CI 4.21%-13.22%),多为一过性;其他次要终点两组无显著差异。
  • CEA与CAS的远期再狭窄风险相似(OR 0.98, 95%CI 0.39-2.49, p=0.95)。
  • 校正初次手术方式不影响结论。

关键数值与推荐

  • 主要终点:TIA或任何卒中;次要终点包括技术成功、30天内死亡、心梗、局部并发症、脑高灌注综合征、颅神经损伤、心律失常、再狭窄、再血运重建和长期生存。

临床怎么用

  • CAS与CEA均可用于初次颈动脉复发狭窄,但基于结果CAS似乎更可取。
  • 患者应由多学科团队进行严格评估。

局限性

  • 原文述纳入研究质量有限,多为回顾性和非随机设计。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Carotid artery restenosis can occur after both carotid artery stenting (CAS) and carotid endarterectomy (CEA). This systematic review and meta-analysis aim to determine which revascularization technique, CAS, or CEA, is superior for treating primary carotid restenosis, irrespective of the initial revascularization method used. DESIGN: Systematic review and meta-analysis. METHODS: MEDLINE, EMBASE, and Cochrane Central Register of Controlled Trials (CENTRALs) databases were searched for eligible studies on December 19th, 2023. The Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) statement was followed. Primary endpoint was the occurrence of transient ischemic attack (TIA) or any stroke. Secondary endpoints were technical success, death within 30 days, myocardial infarction (MI), local complications, cerebral hyperperfusion syndrome (CHS), cranial nerve injury (CNI), dys-/arrythmia, secondary restenosis, repeat revascularization, and long-term survival. Results were adjusted for symptomatic status and primary treatment strategy. RESULTS: Nineteen studies comprising 10,171 procedures in 10,041 patients were included. Baseline characteristics were comparable between groups. Main findings were (1) No difference in primary outcome; however, if adjusted for symptomatic status the rate of TIA/any stroke is higher (OR: 2.05, 95% CI: 1.29-3.27, p < 0.01) after CEA compared to CAS; (2) Significant higher rate of MI (OR: 1.85, 95% CI: 1.19-2.86, p < 0.01) after CEA; (3) Besides CNI, which appears to be commonly temporary and occurred only after CEA (7.56%, 95% CI: 4.21%-13.22%), no significant differences in other secondary endpoints were observed between groups. Long-term risk of secondary restenosis was similar between CEA compared to CAS (OR: 0.98, 95% CI: 0.39-2.49, p = 0.95); (4) Correction for the index procedure did not affect conclusions. CONCLUSION: Based on limited-quality studies, mostly retrospective and nonrandomized in design, both CAS and CEA represent feasible treatment approaches for patients with primary restenosis, with comparable primary outcome between the two groups. However, based on the obtained results, CAS appears to be preferable. Patients should be critically evaluated in a multidisciplinary team and further research is desirable.Clinical ImpactThis review expands on previous studies by incorporating a larger patient cohort and more recent literature while offering new insights into restenosis. Unlike earlier research, this study uniquely evaluates first repeat revascularization outcomes (CAS and CEA) independently of the initial procedure, suggesting that patient and plaque characteristics might be more influential than the primary technique. Sensitivity analysis confirmed this, as stratification by index procedure did not alter conclusions. Although lower TIA/stroke and mortality rates were observed in CAS-treated patients, these findings were not statistically significant in the overall group. These results may help guide clinical decision-making for optimal restenosis management.

来源:J Endovasc Ther,查看原文。版权归原作者所有。

引用

  1. Kök M, Röder F, Bokkers RPH, et al. A Systematic Review and Meta-Analysis of Outcome After Repeat Revascularization for Primary Carotid Artery Restenosis. J Endovasc Ther. 2025. PMID: 40542821. doi:10.1177/15266028251325054

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。